JP2024501453A5 - - Google Patents
Info
- Publication number
- JP2024501453A5 JP2024501453A5 JP2023535317A JP2023535317A JP2024501453A5 JP 2024501453 A5 JP2024501453 A5 JP 2024501453A5 JP 2023535317 A JP2023535317 A JP 2023535317A JP 2023535317 A JP2023535317 A JP 2023535317A JP 2024501453 A5 JP2024501453 A5 JP 2024501453A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- seq
- cdr
- alkyldiyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063124353P | 2020-12-11 | 2020-12-11 | |
| US63/124,353 | 2020-12-11 | ||
| PCT/US2021/062797 WO2022125891A2 (en) | 2020-12-11 | 2021-12-10 | Anti-cea immunoconjugates, and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024501453A JP2024501453A (ja) | 2024-01-12 |
| JP2024501453A5 true JP2024501453A5 (enExample) | 2024-12-10 |
Family
ID=79425667
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023535317A Withdrawn JP2024501453A (ja) | 2020-12-11 | 2021-12-10 | 抗ｃｅａイムノコンジュゲート、及びそれらの使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240238430A1 (enExample) |
| EP (1) | EP4259210A2 (enExample) |
| JP (1) | JP2024501453A (enExample) |
| CN (1) | CN116635084A (enExample) |
| CA (1) | CA3200051A1 (enExample) |
| WO (1) | WO2022125891A2 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3200056A1 (en) | 2020-12-11 | 2022-06-16 | Shelley Erin ACKERMAN | Anti-her2 immunoconjugates, and uses thereof |
| WO2023154318A1 (en) * | 2022-02-09 | 2023-08-17 | Bolt Biotherapeutics, Inc. | Anti-tr0p2, aminobenzazepine immunoconjugates, and uses thereof |
| WO2024173387A1 (en) | 2023-02-14 | 2024-08-22 | Bolt Biotherapeutics, Inc. | Aza-benzazepine immunoconjugates, and uses thereof |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3101690B2 (ja) | 1987-03-18 | 2000-10-23 | エス・ビィ・２・インコーポレイテッド | 変性抗体の、または変性抗体に関する改良 |
| US5874540A (en) | 1994-10-05 | 1999-02-23 | Immunomedics, Inc. | CDR-grafted type III anti-CEA humanized mouse monoclonal antibodies |
| AU5345901A (en) | 2000-04-13 | 2001-10-30 | Univ Rockefeller | Enhancement of antibody-mediated immune responses |
| US7232888B2 (en) | 2002-07-01 | 2007-06-19 | Massachusetts Institute Of Technology | Antibodies against tumor surface antigens |
| WO2005086875A2 (en) | 2004-03-11 | 2005-09-22 | City Of Hope | A humanized anti-cea t84.66 antibody and uses thereof |
| TR201808537T4 (tr) | 2004-09-23 | 2018-07-23 | Genentech Inc | Sistein değiştirilmiş antikorlar ve konjugatlar. |
| US20070014795A1 (en) | 2004-12-30 | 2007-01-18 | Dhodapkar Madhav V | Compositions and methods for enhanced dendritic cell maturation and function |
| AU2006312148B2 (en) | 2005-11-07 | 2012-04-12 | The Rockefeller University | Reagents, methods and systems for selecting a cytotoxic antibody or variant thereof |
| NZ569204A (en) | 2005-12-21 | 2012-03-30 | Micromet Ag | Pharmaceutical compositions with resistance to soluble CEA - comprising antibodies that bind to CD3 and CEA |
| PE20090245A1 (es) | 2007-05-08 | 2009-03-17 | Genentech Inc | Anticuerpos anti-muc16 disenados con cisteina y conjugados de anticuerpos y farmacos |
| BRPI0818780A2 (pt) | 2007-10-19 | 2015-04-22 | Genentech Inc | Anticorpo anti-tenb2 planejados por cisteína e conjugados de medicamento com anticorpos |
| EP2640727B1 (en) | 2010-11-17 | 2015-05-13 | Genentech, Inc. | Alaninyl maytansinol antibody conjugates |
| KR101981342B1 (ko) | 2011-03-02 | 2019-05-22 | 로슈 글리카트 아게 | Cea 항체 |
| PT3199552T (pt) | 2012-11-20 | 2020-03-25 | Sanofi Sa | Anticorpos anti-ceacam5 e suas utilizações |
| HRP20210977T1 (hr) | 2014-02-10 | 2021-09-17 | Merck Patent Gmbh | Ciljano inhibiranje tgf beta |
| JP6805142B2 (ja) | 2014-11-21 | 2020-12-23 | ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ | Ｃｄ７３に対する抗体およびその使用 |
| EP3849971A2 (en) * | 2018-09-12 | 2021-07-21 | Silverback Therapeutics, Inc. | Substituted benzazepine compounds, conjugates, and uses thereof |
| EP3983080A1 (en) * | 2019-06-13 | 2022-04-20 | Bolt Biotherapeutics, Inc. | Macromolecule-supported aminobenzazepine compounds |
| JP2022537158A (ja) * | 2019-06-13 | 2022-08-24 | ボルト バイオセラピューティクス、インコーポレーテッド | アミノベンズアゼピン化合物、イムノコンジュゲート、及びそれらの使用 |
| CA3176626A1 (en) * | 2020-05-08 | 2021-11-11 | David Dornan | Elastase-substrate, peptide linker immunoconjugates, and uses thereof |
-
2021
- 2021-12-10 WO PCT/US2021/062797 patent/WO2022125891A2/en not_active Ceased
- 2021-12-10 CN CN202180083382.7A patent/CN116635084A/zh active Pending
- 2021-12-10 CA CA3200051A patent/CA3200051A1/en active Pending
- 2021-12-10 JP JP2023535317A patent/JP2024501453A/ja not_active Withdrawn
- 2021-12-10 EP EP21841071.0A patent/EP4259210A2/en not_active Withdrawn
- 2021-12-10 US US18/038,904 patent/US20240238430A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022553702A5 (enExample) | ||
| JP2022537158A5 (enExample) | ||
| JP2023553421A5 (ja) | 抗ｃｅａ免疫複合体、及びその使用 | |
| JP2023524271A5 (enExample) | ||
| JP2024523453A5 (enExample) | ||
| JP2022549510A5 (enExample) | ||
| JP2023552790A5 (enExample) | ||
| JP2024521629A (ja) | 抗体薬物コンジュゲート、及びその調製方法及びその使用 | |
| JP2023552792A5 (enExample) | ||
| JP2024545233A5 (enExample) | ||
| JP2022546110A5 (enExample) | ||
| JP2023552791A5 (enExample) | ||
| EP4514396A1 (en) | Antibody-drug conjugates and preparation methods and use thereof | |
| JP2022550851A5 (enExample) | ||
| JP2024509099A5 (enExample) | ||
| JP2022554094A5 (enExample) | ||
| JP2025533758A (ja) | 抗体－薬物複合体並びにその調製方法及び使用 | |
| JP2024511088A5 (enExample) | ||
| JP2024533356A5 (enExample) | ||
| JP2025541673A (ja) | ヘテロ環化合物並びにその製造方法及び用途 | |
| WO2024227439A1 (zh) | 具有靶向作用的偶联物及其制备方法和用途 | |
| JP2026504636A5 (enExample) | ||
| CN121001750A (zh) | 杂环类化合物及其制备方法和用途 | |
| CN120957761A (zh) | 具有靶向作用的偶联物及其制备方法和用途 | |
| JP2025539841A5 (enExample) |